Alyeska Investment Group
IRON icon

Alyeska Investment Group’s Disc Medicine IRON Stock Holding History

Alyeska Investment Group’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.14M Hold
125,000
– – 0.02% 440
2026
Q1 		$7.99M Buy
125,000
+75,000
+150% +$5.2M 0.02% 425
2025
Q4 		$3.97M Buy
+50,000
New +$4.22M 0.01% 480
2022
Q1 		– Sell
-21,190
Closed -$1.85M – 622
2021
Q4 		$1.85M Buy
21,190
+1,742
+9% +$171K 0.02% 454
2021
Q3 		$2.36M Sell
19,448
-8,471
-30% -$1.16M 0.03% 480
2021
Q2 		$5.42M Buy
27,919
+9,915
+55% +$3.26M 0.06% 325
2021
Q1 		$6.34M Buy
+18,004
New +$8.03M 0.08% 285

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Alyeska Investment Group's IRON Position: Q2 2026 in Review

Alyeska Investment Group held its Disc Medicine (IRON) position steady in Q2 2026 at 125,000 shares worth $9.14M. The position accounts for 0.02% of the portfolio, ranked #440.

Alyeska Investment Group first reported a position in IRON in Q1 2021 and has held it in 7 quarters since. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Alyeska Investment Group held 125,000 shares of Disc Medicine worth $9.14M as of Q2 2026.
  • Alyeska Investment Group left its Disc Medicine share count unchanged in Q2 2026.
  • Disc Medicine made up 0.02% of Alyeska Investment Group's portfolio in Q2 2026, its #440 holding.
  • Alyeska Investment Group first reported a position in Disc Medicine in Q1 2021 and has held it in 7 quarters since.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.